Literature DB >> 32475279

Risk factors for manipulation under anaesthesia after total knee arthroplasty.

Paul Knapp1, Luke Weishuhn2, Natalie Pizzimenti3, David C Markel1,4.   

Abstract

AIMS: Postoperative range of movement (ROM) is an important measure of successful and satisfying total knee arthroplasty (TKA). Reduced postoperative ROM may be evident in up to 20% of all TKAs and negatively affects satisfaction. To improve ROM, manipulation under anaesthesia (MUA) may be performed. Historically, a limited ROM preoperatively was used as the key harbinger of the postoperative ROM. However, comorbidities may also be useful in predicting postoperative stiffness. The goal was to assess preoperative comorbidities in patients undergoing TKA relative to incidence of postoperative MUA. The hope is to forecast those who may be at increased risk and determine if MUA is an effective form of treatment.
METHODS: Prospectively collected data of TKAs performed at our institution's two hospitals from August 2014 to August 2018 were evaluated for incidence of MUA. Comorbid conditions, risk factors, implant component design and fixation method (cemented vs cementless), and discharge disposition were analyzed. Overall, 3,556 TKAs met the inclusion criteria. Of those, 164 underwent MUA.
RESULTS: Patients with increased age and body mass index (BMI) had decreased likelihood of MUA. For every one-year increase in age, the likelihood of MUA decreased by 4%. Similarly, for every one-unit increase in BMI the likelihood of MUA decreased by 6%. There were no differences in incidence of MUA between component type/design or fixation method. Current or former smokers were more likely to have no MUA. Surprisingly, patients discharged to home health service or skilled nursing facility were approximately 40% and 70% less likely than those discharged home with outpatient therapy to be in the MUA group. MUA was effective, with a mean increased ROM of 32.81° (SD 19.85°; -15° to 90°).
CONCLUSION: Younger, thinner patients had highest incidence of MUA. Effect of discharge disposition on rate of MUA was an important finding and may influence surgeons' decisions. Interestingly, use of cement and component design (constraint) did not impact incidence of MUA. Level of Evidence II: Prospective cohort study. Cite this article: Bone Joint J 2020;102-B(6 Supple A):66-72.

Entities:  

Keywords:  Comorbid conditions; Manipulation under anesthesia; Total knee arthroplasty

Mesh:

Year:  2020        PMID: 32475279     DOI: 10.1302/0301-620X.102B6.BJJ-2019-1580.R1

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  5 in total

1.  A matched cohort study between cementless TKA and cemented TKA shows a reduction in tourniquet time and manipulation rate.

Authors:  J A Dubin; G H Westrich
Journal:  J Orthop       Date:  2020-09-18

2.  Factors affecting range of motion following two-stage revision arthroplasty for chronic periprosthetic knee infection.

Authors:  Doo-Yeol Kim; Young-Chae Seo; Chang-Wan Kim; Chang-Rack Lee; Soo-Hwan Jung
Journal:  Knee Surg Relat Res       Date:  2022-07-18

3.  Impact of intra-operative predictive ligament balance on post-operative balance and patient outcome in TKA: a prospective multicenter study.

Authors:  John M Keggi; Edgar A Wakelin; Jan A Koenig; Jeffrey M Lawrence; Amber L Randall; Corey E Ponder; Jeffrey H DeClaire; Sami Shalhoub; Stephen Lyman; Christopher Plaskos
Journal:  Arch Orthop Trauma Surg       Date:  2021-07-13       Impact factor: 3.067

4.  Patients undergoing manipulation after total knee arthroplasty are at higher risk of revision within 2 years.

Authors:  Senthil Sambandam; Varatharaj Mounasamy; Dane Wukich
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-03-24

5.  Excellent and Good Results Treating Stiffness with Early and Late Manipulation after Unrestricted Caliper-Verified Kinematically Aligned TKA.

Authors:  Adithya Shekhar; Stephen M Howell; Alexander J Nedopil; Maury L Hull
Journal:  J Pers Med       Date:  2022-02-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.